I have not be involved with the company that long but going on my experience with biotecs fast tracked still means approval is still a few years away . Some things can take almost a decade and I would guarantee you that BSI would have taken a least a year to even come up with the protocol for the trial . Just some advise on investing in these industries , Don’t believe you will get approvals in the near future till trials have begun . Allways look ahead , if the company is not breaking even make sure they have at least 12 mths funding . I am pretty confident at this stage Oncosil will get this through in the very near future . I have a very large holding in a unlisted company Qbiotics and they are developing a cancer drug . So far this drug has taken about 8 yrs , it will be approved mid year as a vet drug in US and EU but still has about 2 to 3 yrs to go in human trials and final approval . Unfortunately Aust companies don’t seem to have any clout in getting trials OS especially with the FDA
- Forums
- ASX - By Stock
- Anyone Left?
OSL
oncosil medical ltd
Add to My Watchlist
15.7%
!
$1.18

I have not be involved with the company that long but going on...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.18 |
Change
0.160(15.7%) |
Mkt cap ! $15.71M |
Open | High | Low | Value | Volume |
$1.05 | $1.18 | $1.03 | $37.05K | 34.74K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13759 | $1.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 4822 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7 | 1.135 |
1 | 15468 | 1.105 |
1 | 425 | 1.100 |
1 | 7500 | 1.080 |
1 | 15000 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 1980 | 2 |
1.175 | 835 | 1 |
1.180 | 6234 | 1 |
1.200 | 65603 | 3 |
1.230 | 45403 | 2 |
Last trade - 12.20pm 26/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online